Drug Trial Radar · NCT00486434
Efficacy and Safety of Oral Salmon Calcitonin in Patients With Knee Osteoarthritis
Last checked: Nov 19, 2026Latest source record: Apr 26, 2019 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
1,176
Actual
Start
May 2007
Primary completion
Sep 2010
Study completion Sep 2010
Sponsor
- Lead sponsor
- Nordic Bioscience A/SIndustry
- Sponsor type
- Industry
- Collaborators
- Novartis
- First posted
- Jun 14, 2007
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 51 years, up to 80 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this Phase III study is to evaluate the efficacy and safety of oral salmon calcitonin in the treatment of patients with osteoarthritis of the knee.
Conditions
- Osteoarthritis
Interventions
SMC021 Oral CalcitoninDrug
0.8mg SMC021 (Oral Calcitoinin) twice daily
SMC021 PlaceboDrug
Placebo orally, twice daily
Primary outcomes
What the sponsor says the trial is designed to measure.
- Joint Space Width (JSW) in the Medial Tibiofemoral Knee Joint in Signal Knee Measured by X-ray After 24 Months.Time frame: Change from baseline to 24 months
- Western Ontario and McMaster Universities Arthritis Index (WOMAC) Pain Subscore in the Signal KneeTime frame: Change from baseline to 24 months
- Western Ontario and McMaster Universities Arthritis Index (WOMAC) Function Subscore in the Signal Knee.Time frame: Change from baseline to 24 months
Locations
9 sites in 6 countries. Site status is shown where the registry gives one.
CCBR Czech
Pardubice, Czechia
CCBR Aalborg
Aalborg, Denmark
CCBR Ballerup
Ballerup Municipality, Denmark
CCBR Vejle
Vejle, Denmark
CCBR Estonia
Tallinn, Estonia
CCBR Hong Kong
Hong Kong, Hong Kong
Centrum Osteoporozy i Chorób Kostno Stawowych, ul. Waryńskiego 6/2
Bialystok, Poland
CCBR Poland
Warsaw, Poland
CCBR Romania
Bucharest, Romania
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.